Subscribe
shutterstock_549156772_ken_wolter
Ken Wolter / Shutterstock.com
26 October 2021AmericasMuireann Bolger

St Jude recovers partial attorney fees in heart catheter case

St Jude Medical will be able to claw back some of the attorney fees and expenses it incurred defending a suit filed by Niazi Licensing Corporation (NLC) in a dispute over a patent covering a heart catheter.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Abbott unit prevails in dispute over catheter patent
25 March 2021   In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.
Americas
Abbott must face HIV testing patent suit, rules judge
4 December 2020   Abbott Laboratories must face allegations brought by Grifols Diagnostic and a Novartis subsidiary that its HIV testing products infringe a patent covering a method to create HIV proteins using recombinant DNA.
Medtech
Fed Circ revives claims in St Jude’s catheter patent suit
12 April 2022   Abbot-owned St Jude Medical will have to defend claims that its catheters infringe a company’s revived patent.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Medtech
Fed Circ revives claims in St Jude’s catheter patent suit
12 April 2022   Abbot-owned St Jude Medical will have to defend claims that its catheters infringe a company’s revived patent.
Americas
Abbott must face HIV testing patent suit, rules judge
4 December 2020   Abbott Laboratories must face allegations brought by Grifols Diagnostic and a Novartis subsidiary that its HIV testing products infringe a patent covering a method to create HIV proteins using recombinant DNA.
Americas
Abbott unit prevails in dispute over catheter patent
25 March 2021   In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.

More on this story

Medtech
Fed Circ revives claims in St Jude’s catheter patent suit
12 April 2022   Abbot-owned St Jude Medical will have to defend claims that its catheters infringe a company’s revived patent.
Americas
Abbott must face HIV testing patent suit, rules judge
4 December 2020   Abbott Laboratories must face allegations brought by Grifols Diagnostic and a Novartis subsidiary that its HIV testing products infringe a patent covering a method to create HIV proteins using recombinant DNA.
Americas
Abbott unit prevails in dispute over catheter patent
25 March 2021   In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?